Advertisement
Editorial|Articles in Press

Preface

Published:March 09, 2023DOI:https://doi.org/10.1016/j.cld.2023.02.001
Preface
Next ArticleRoles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
      Figure thumbnail fx1
      Zobair M. Younossi, MD, MPH, Editor
      Epidemiologic data published in 2023 suggest that nonalcoholic fatty liver (NAFLD) and nonalcoholic steatohepatitis (NASH) affect around 30% and 5% of the world population and is on track to become the most common cause of cirrhosis and hepatocellular carcinoma (HCC), the most common cause for liver death, and the most common indication for liver transplantation. Driven by the global pandemic of obesity and type 2 diabetes, the global burden of NAFLD can be measured not only in clinical terms (liver mortality, cirrhosis, HCC) but also by its negative impact on patient-reported outcomes and the economic burden of the disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Publication history

      Published online: March 09, 2023

      Publication stage

      In Press Corrected Proof

      Identification

      DOI: https://doi.org/10.1016/j.cld.2023.02.001

      Copyright

      © 2023 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX